Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Weber

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Visceral Medicine|August 10, 2021
The Psychosocial Burden on Liver Transplant Recipients during the COVID-19 PandemicSabine Weber, Stephanie Rek, Daniela Eser-Valeri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2022
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI RegistryEinar S Björnsson, Camilla Stephens, Edmond Atallah, et al.
Inflammatory Bowel Diseases|March 19, 2020
Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX TherapyAlexander Schnell, Benedikt Schwarz, Mandy Wahlbuhl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2025
IgM Antibodies Targeting Malondialdehyde Promote Complement-Mediated Liver Injury in Alcohol-Related Liver DiseaseDragana Rajcic, Beatriz Pereira da Silva, Taras Baranovskyi, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Ebiomedicine|March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injuryMaria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Visceral Medicine|August 10, 2021
The Psychosocial Burden on Liver Transplant Recipients during the COVID-19 PandemicSabine Weber, Stephanie Rek, Daniela Eser-Valeri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2022
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI RegistryEinar S Björnsson, Camilla Stephens, Edmond Atallah, et al.
Inflammatory Bowel Diseases|March 19, 2020
Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX TherapyAlexander Schnell, Benedikt Schwarz, Mandy Wahlbuhl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2025
IgM Antibodies Targeting Malondialdehyde Promote Complement-Mediated Liver Injury in Alcohol-Related Liver DiseaseDragana Rajcic, Beatriz Pereira da Silva, Taras Baranovskyi, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Ebiomedicine|March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injuryMaria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Pageof 6